Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -14.70 |
peg ratio | 1.96 |
price to book ratio | 9.81 |
price to sales ratio | 98.59 |
enterprise value multiple | -14.39 |
price fair value | 9.81 |
profitability ratios | |
---|---|
gross profit margin | 95.66% |
operating profit margin | -706.41% |
pretax profit margin | -668.54% |
net profit margin | -668.54% |
return on assets | -48.33% |
return on equity | -71.78% |
return on capital employed | -61.21% |
liquidity ratio | |
---|---|
current ratio | 5.98 |
quick ratio | 5.93 |
cash ratio | 1.31 |
efficiency ratio | |
---|---|
days of inventory outstanding | 945.31 |
operating cycle | 1,088.63 |
days of payables outstanding | 4,985.91 |
cash conversion cycle | -3,897.28 |
receivables turnover | 2.55 |
payables turnover | 0.07 |
inventory turnover | 0.39 |
debt and solvency ratios | |
---|---|
debt ratio | 0.11 |
debt equity ratio | 0.15 |
long term debt to capitalization | 0.13 |
total debt to capitalization | 0.13 |
interest coverage | -70.39 |
cash flow to debt ratio | -3.65 |
cash flow ratios | |
---|---|
free cash flow per share | -19.93 |
cash per share | 45.92 |
operating cash flow per share | -19.82 |
free cash flow operating cash flow ratio | 1.01 |
cash flow coverage ratios | -3.65 |
short term coverage ratios | -490.91 |
capital expenditure coverage ratio | -187.16 |
Frequently Asked Questions
Madrigal Pharmaceuticals, Inc. (MDGL) published its most recent earnings results on 31-10-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)'s trailing twelve months ROE is -71.78%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Madrigal Pharmaceuticals, Inc. (MDGL) currently has a ROA of -48.33%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
MDGL reported a profit margin of -668.54% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.98 in the most recent quarter. The quick ratio stood at 5.93, with a Debt/Eq ratio of 0.15.